KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $8,851,000 | -0.2% | 69,966 | 0.0% | 0.05% | -2.0% |
Q1 2022 | $8,871,000 | -3.2% | 69,966 | 0.0% | 0.05% | +13.3% |
Q4 2021 | $9,166,000 | +7.1% | 69,966 | 0.0% | 0.04% | +18.4% |
Q3 2021 | $8,559,000 | +7.3% | 69,966 | 0.0% | 0.04% | +8.6% |
Q2 2021 | $7,975,000 | -5.2% | 69,966 | 0.0% | 0.04% | -2.8% |
Q1 2021 | $8,412,000 | +18.3% | 69,966 | 0.0% | 0.04% | +33.3% |
Q4 2020 | $7,108,000 | +18.2% | 69,966 | -10.0% | 0.03% | +12.5% |
Q3 2020 | $6,014,000 | -34.2% | 77,776 | -5.1% | 0.02% | -40.0% |
Q2 2020 | $9,137,000 | +202.3% | 81,976 | +95.3% | 0.04% | +110.5% |
Q1 2020 | $3,022,000 | – | 41,976 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |